145 related articles for article (PubMed ID: 9190913)
1. Role of CD19 tyrosine 391 in synergistic activation of B lymphocytes by coligation of CD19 and membrane Ig.
Li X; Sandoval D; Freeberg L; Carter RH
J Immunol; 1997 Jun; 158(12):5649-57. PubMed ID: 9190913
[TBL] [Abstract][Full Text] [Related]
2. The CD19 complex of B lymphocytes. Activation of phospholipase C by a protein tyrosine kinase-dependent pathway that can be enhanced by the membrane IgM complex.
Carter RH; Tuveson DA; Park DJ; Rhee SG; Fearon DT
J Immunol; 1991 Dec; 147(11):3663-71. PubMed ID: 1719083
[TBL] [Abstract][Full Text] [Related]
3. Membrane IgM-induced tyrosine phosphorylation of CD19 requires a CD19 domain that mediates association with components of the B cell antigen receptor complex.
Carter RH; Doody GM; Bolen JB; Fearon DT
J Immunol; 1997 Apr; 158(7):3062-9. PubMed ID: 9120258
[TBL] [Abstract][Full Text] [Related]
4. Convergence of CD19 and B cell antigen receptor signals at MEK1 in the ERK2 activation cascade.
Li X; Carter RH
J Immunol; 1998 Dec; 161(11):5901-8. PubMed ID: 9834070
[TBL] [Abstract][Full Text] [Related]
5. CD38 ligation in human B cell progenitors triggers tyrosine phosphorylation of CD19 and association of CD19 with lyn and phosphatidylinositol 3-kinase.
Kitanaka A; Ito C; Coustan-Smith E; Campana D
J Immunol; 1997 Jul; 159(1):184-92. PubMed ID: 9200454
[TBL] [Abstract][Full Text] [Related]
6. Signaling through the EBV/C3d receptor (CR2, CD21) in human B lymphocytes: activation of phosphatidylinositol 3-kinase via a CD19-independent pathway.
Bouillie S; Barel M; Frade R
J Immunol; 1999 Jan; 162(1):136-43. PubMed ID: 9886379
[TBL] [Abstract][Full Text] [Related]
7. The signaling activity of murine CD19 is regulated during cell development.
Krop I; Shaffer AL; Fearon DT; Schlissel MS
J Immunol; 1996 Jul; 157(1):48-56. PubMed ID: 8683154
[TBL] [Abstract][Full Text] [Related]
8. Membrane Ig cross-linking regulates phosphatidylinositol 3-kinase in B lymphocytes.
Gold MR; Chan VW; Turck CW; DeFranco AL
J Immunol; 1992 Apr; 148(7):2012-22. PubMed ID: 1372019
[TBL] [Abstract][Full Text] [Related]
9. Differential phosphorylation of functional tyrosines in CD19 modulates B-lymphocyte activation.
Ishiura N; Nakashima H; Watanabe R; Kuwano Y; Adachi T; Takahashi Y; Tsubata T; Okochi H; Tamaki K; Tedder TF; Fujimoto M
Eur J Immunol; 2010 Apr; 40(4):1192-204. PubMed ID: 20101619
[TBL] [Abstract][Full Text] [Related]
10. Extracellular signal-regulated kinase-2, but not c-Jun NH2-terminal kinase, activation correlates with surface IgM-mediated apoptosis in the WEHI 231 B cell line.
Lee JR; Koretzky GA
J Immunol; 1998 Aug; 161(4):1637-44. PubMed ID: 9712025
[TBL] [Abstract][Full Text] [Related]
11. Modulation of signaling via the B cell antigen receptor by CD21, the receptor for C3dg and EBV.
Luxembourg AT; Cooper NR
J Immunol; 1994 Nov; 153(10):4448-57. PubMed ID: 7525704
[TBL] [Abstract][Full Text] [Related]
12. Systematic analysis of the role of CD19 cytoplasmic tyrosines in enhancement of activation in Daudi human B cells: clustering of phospholipase C and Vav and of Grb2 and Sos with different CD19 tyrosines.
Brooks SR; Li X; Volanakis EJ; Carter RH
J Immunol; 2000 Mar; 164(6):3123-31. PubMed ID: 10706702
[TBL] [Abstract][Full Text] [Related]
13. CD19 regulates B lymphocyte responses to transmembrane signals.
Fujimoto M; Poe JC; Inaoki M; Tedder TF
Semin Immunol; 1998 Aug; 10(4):267-77. PubMed ID: 9695183
[TBL] [Abstract][Full Text] [Related]
14. Regulation of B lymphocyte development and activation by the CD19/CD21/CD81/Leu 13 complex requires the cytoplasmic domain of CD19.
Sato S; Miller AS; Howard MC; Tedder TF
J Immunol; 1997 Oct; 159(7):3278-87. PubMed ID: 9317126
[TBL] [Abstract][Full Text] [Related]
15. Defective CD19-dependent signaling in B-1a and B-1b B lymphocyte subpopulations.
Sen G; Wu HJ; Bikah G; Venkataraman C; Robertson DA; Snow EC; Bondada S
Mol Immunol; 2002 Sep; 39(1-2):57-68. PubMed ID: 12213328
[TBL] [Abstract][Full Text] [Related]
16. CD19 expression levels regulate B lymphocyte development: human CD19 restores normal function in mice lacking endogenous CD19.
Sato S; Steeber DA; Jansen PJ; Tedder TF
J Immunol; 1997 May; 158(10):4662-9. PubMed ID: 9144478
[TBL] [Abstract][Full Text] [Related]
17. Antibody-induced CD3-CD4 coligation inhibits TCR/CD3 activation in the absence of costimulatory signals in normal mouse CD4(+) T lymphocytes.
Portolés P; de Ojeda G; Criado G; Fernández-Centeno E; Rojo JM
Cell Immunol; 1999 Aug; 195(2):96-109. PubMed ID: 10448009
[TBL] [Abstract][Full Text] [Related]
18. Differential induction of DNA-binding activities following CD19 cross-linking in human B lineage cells.
Weng WK; Shah N; O'Brien D; Van Ness B; LeBien TW
J Immunol; 1997 Dec; 159(11):5502-8. PubMed ID: 9548490
[TBL] [Abstract][Full Text] [Related]
19. Signaling through CD19 activates Vav/mitogen-activated protein kinase pathway and induces formation of a CD19/Vav/phosphatidylinositol 3-kinase complex in human B cell precursors.
Weng WK; Jarvis L; LeBien TW
J Biol Chem; 1994 Dec; 269(51):32514-21. PubMed ID: 7528218
[TBL] [Abstract][Full Text] [Related]
20. CD19 is a substrate of the antigen receptor-associated protein tyrosine kinase in human B cells.
Roifman CM; Ke S
Biochem Biophys Res Commun; 1993 Jul; 194(1):222-5. PubMed ID: 7687428
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
